All Immunology articles – Page 6
-
NewsStudy reveals early immune protection in the womb
Researchers have discovered that fetuses can manage their own immune responses to combat diseases and infections like Zika.
-
NewsMouse gut fungus reveals secrets of symbiosis and allergy
A fungus discovered in the mouse stomach may hold a key to fungal evolution within the gastrointestinal tract, according to new research. The finding suggests that preclinical studies until now have overlooked a major influencer of mouse physiology.
-
NewsResearchers develop light-guided siRNA delivery system based on cyanobacteria
In a study published in Cell Reports Physical Science on Nov. 25, a research team led by Prof. Cai Lintao from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences reported its development of an innovative intelligent light-guided biohybrid system, the CTPA/siCSF1R system, to target tumor-associated ...
-
NewsScientists implicate a novel cellular protein in hepatitis A infection
Viruses have thrived in humans for tens of thousands of years, evolving to take advantage of the machinery of cells to replicate and survive inside us. Some can slip past our defenses and invade without even causing symptoms. Source: Shirasaki et al. (2024) (Left) Liver cells infected with ...
-
NewsNew mechanism to fund clinical studies addressing the impact of diet, nutrition, and microbiome on lupus
The unique IDEAL (Investigate Dietary Approaches for Lupus) Initiative will provide multi-disciplinary research teams the opportunity to conduct innovative and much-needed research of diet in lupus.
-
NewsSimple COVID-19 vaccine can be stored at room temperature and administered as a nasal spray
Researchers have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored at room temperature and administered as a nasal spray.
-
NewsStudy uncovers key heart responses to viral infection
Researchers at the University of Virginia have made a significant discovery that could change how doctors treat viral infections of the heart. Source: UVA Engineering Kevin Janes, University of Virginia John Marshall Money Professor, Department of Biomedical Engineering and Department of Biochemistry & Molecular Genetics. The ...
-
NewsProbiotic delivers anticancer drug to the gut
Researchers have engineered a probiotic that delivers immunotherapy directly to the gut to shrink tumors in mice, offering a potentially promising oral drug for hard-to-reach cancers.
-
NewsHuman antibodies could prevent the malaria parasite from causing life-threatening infections
Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than 600,000 people every year – most of them African children under five. In a new study, published in the journal Nature, researchers from EMBL Barcelona, the University of Texas, the ...
-
NewsWomen’s health company Freya Biosciences announces key $10.4m strategic investment
Freya Biosciences, a transatlantic biotech company specializing in women’s health, has announced a major strategic investment which will be used to develop microbial immunotherapies for the treatment of bacterial vaginosis.
-
NewsA new technology to isolate immunostimulatory members of the human gut microbiota
Scientists have developed a new technology to isolate a specific subset of gut bacteria that are recognized by IgA antibodies. These ‘IgA-coated’ bacteria are associated with an array of diseases and this proposed new technology has the potential to uncover the mechanisms behind these correlations.
-
NewsZinc deficiency promotes Acinetobacter lung infection: study
Dietary zinc deficiency promotes lung infection by Acinetobacter baumannii bacteria — a leading cause of ventilator-associated pneumonia, according to a new study.
-
NewsNew evidence links gut microbiome to chronic disease outcomes
A new review consolidates recent findings that demonstrate a causal role for the gut microbiome in the progression of multiple diseases, ranging from gastrointestinal conditions to immune-related and psychiatric disorders.
-
NewsKey influenza-severity risk factor found hiding in plain sight on our antibodies
Viruses are the fastest-evolving biological entity on earth. This fact explains why we need flu shots every year: Seasonal influenza perennially outwits the immunity we’ve acquired from previous vaccinations or infections. Source: Yuki999 H1N1 virus Some new strains are rougher than others. The 1918 flu pandemic killed ...
-
NewsScientists exploit shape change to reveal how immune cells sniff out pathogens
Researchers are using an innovative method to watch immune receptors go about their business, based on the fact that cells tend to change their form when they come into contact with a signal molecule.
-
NewsSARS-CoV-2 ‘steals’ our proteins to protect itself from the immune system
Researchers at the Medical University of Vienna and the Medical University of Innsbruck discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly impairs viral clearance which may affect the course of ...
-
NewsFaster measurement of response to antibiotic treatment in sepsis patients using Dimeric HNL
The biomarker human neutrophil lipocalin HNL, which was previously shown to be a useful indicator of bacterial infections, may also in the form of Dimeric HNL be used to effectively monitor the success of antibiotic treatment in sepsis.
-
NewsGut microbiome changes linked to onset of clinically evident rheumatoid arthritis
Changes in the make-up of the gut microbiome are linked to the onset of clinically evident rheumatoid arthritis in those at risk of the disease because of genetic, environmental, or immunological factors, suggests a new study.
-
NewsRepeated COVID vaccines enhance mucosal immunity against the virus
New work has found that repeated Covid-19 vaccinations lead to the presence of mucosal antibodies, for example, inside the nose.
-
NewsNovel antibody platform tackles viral mutations
Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies.